Home > Health & Medical > Pharmaceutical > Ivermectin

Ivermectin

Ivermectin is a sixteen-membered macrolide derivative, which is semi-synthesized from avermectin fermented by Streptomyces vermiculum. It belongs to the compound of avermectin, containing ivermectin B1 ( Bla B1b) not less than 93%, of which Bla must not be less than 85%. Ivermectin B1 is 22,23-dihydroabamectin B1.

Product Description

Ivermectin is a sixteen-membered macrolide derivative, which is semi-synthesized from avermectin fermented by Streptomyces vermiculum. It belongs to the compound of avermectin, containing ivermectin B1 ( Bla B1b) not less than 93%, of which Bla must not be less than 85%. Ivermectin B1 is 22,23-dihydroabamectin B1.

Ivermectin

Ivermectin is an FDA-approved medication used to treat parasitic infections in both humans and animals. It works by interfering with the nervous system of parasites, ultimately leading to their death. As a result, it has become a popular choice among healthcare providers and veterinarians.

 

If you're looking for Ivermectin suppliers, please choose Jiayi Ivermectin. To ensure the safe and effective use of Ivermectin, it is recommended to consult with a healthcare provider or a veterinarian. They can provide guidance on proper dosages, potential side effects, and any necessary precautions. With the right information and proper usage, Ivermectin can be a valuable tool in treating parasitic infections.

Ivermectin

Abamectin is a natural compound. Its discoverers, William C. Campbell and Satoshi Omura, won the Nobel Prize in 2015 for their outstanding achievements in combating river blindness and filariasis. Bell Prize in Physiology and Medicine.

 

Ivermectin is a "miracle drug" for the treatment of parasitic diseases that has been in the global market for nearly 40 years. It has been confirmed to be in-depth research in two new indication fields, and one of the new indications has obtained FDA clinical phase 1B The trial license for another indication is being tested in clinical institutions in different countries.

Ivermectin Frequently Asked Questions.

 

Merck's drug ivermectin has been shown to be effective in treating river blindness. Infected patients only need to take Ivermectin® regularly every year to relieve symptoms, relieve pain, and prevent blindness caused by the progression of the disease. In 1987, Merck announced a free donation project for the river blindness drug ivermectin, promising to support the project globally until river blindness is completely eradicated. So far, Merck has donated more than 2.5 billion doses of drugs to more than 30 countries and regions, helping about 250 million river blindness patients. Today, more than 80 million people benefit from it every year.

 

Ivermectin is a broad-spectrum antiparasitic drug, and is the first choice for human anti-intestinal parasitic drugs. It was registered for human use in 1987 and was donated for the treatment of onchocerciasis and lymphatic filariasis. Since the implementation of this large-scale drug donation project, it has helped 1.5 billion people in total. According to the latest data, about 186 million people worldwide still need treatment every year, and about 112 million people can obtain medicines, mainly in the African region.

Ivermectin

Ivermectin CAS#: 70288-86-7, the quality standard meets the latest version of EP/USP/CVP, the packaging specification is 25kg/barrel, or customized by customers. Jiayi has DMF/veterinary drug GMP and is a veterinary drug GMP factory.

Jiayi is one of the leading Ivermectin Suppliers in China.Contact us to get an order.

Home Contact us

Sign In

Username :

Password :